Amgen Rivals Teva With Rituximab Approved For RA

US Market Composed Of Three Biosimilars Plus Rituxan

 
• By Dean Rudge
  
Approved
Two of three biosimilars now have the RA indication • Source: Shutterstock: PSNPJua
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Products

More from Generics Bulletin